Inovio Pharma (INO) Tops Q3 EPS by 4c
Tweet
Share
E-mailGet Alerts INO Hot Sheet
Price: $0.77 --0%
Financial Fact:
License fee and milestone revenue: 2.33M
Today's EPS Names:
MTEX, NSYS, PLNH, More
Financial Fact:
License fee and milestone revenue: 2.33M
Today's EPS Names:
MTEX, NSYS, PLNH, More
Join SI Premium – FREE
Inovio Pharma (NASDAQ: INO) reported Q3 EPS of ($0.09), $0.04 better than the analyst estimate of ($0.13). Revenue for the quarter came in at $390 thousand versus the consensus estimate of $116.67 thousand.
For earnings history and earnings-related data on Inovio Pharma (INO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
- Stantec (STN) Tops Q2 EPS by 47c
- ArriVent BioPharma, Inc. (AVBP) Misses Q2 EPS by 13c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
